Branded medicines sales clawback cap
RecordSTO-GMYPTHCR25-PSS2A2G385-G7T53M
United Kingdom · as of 8 Sep 2026
Branded medicines sales clawback cap in the United Kingdom was 15% (ABPI, published 8 September 2026).
Branded medicines sales clawback cap: every country and year, and how it is measured
- Publisher
- ABPI
- Authority tier
- T2 Official
- Locator
- UK competitive weaknesses
- Retrieved
- 17 Sep 2026
- Status
- Verified
What the source says
Despite a new 15 per cent cap on branded medicines sales clawback rates, the UK's rate on newer medicines remains higher than every other comparator country in the analysis, several of which operate no clawback system at all.
Checked: the figure 15%is stated in this passage. If it does not match, the extraction is wrong and we want to know.
Cite this figure
APA
Association of the British Pharmaceutical Industry. (2026). Green shoots for UK pharma investment, but delivery will decide whether they take root. Retrieved September 17, 2026, from https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Via StatOrigin, https://statorigin.org/stat/stat_GMYPTHCR25PSS2A2G385G7T53M
Other formats: MLA, Chicago, BibTeX
- MLA
- Association of the British Pharmaceutical Industry. "Green shoots for UK pharma investment, but delivery will decide whether they take root." 2026, https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed 17 Sept. 2026 via StatOrigin, https://statorigin.org/stat/stat_GMYPTHCR25PSS2A2G385G7T53M.
- Chicago
- Association of the British Pharmaceutical Industry. "Green shoots for UK pharma investment, but delivery will decide whether they take root." 2026. https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed September 17, 2026. Cited from StatOrigin, https://statorigin.org/stat/stat_GMYPTHCR25PSS2A2G385G7T53M.
- BibTeX
- @misc{abpi2026brandedg7t53m, author = {{Association of the British Pharmaceutical Industry}}, title = {Green shoots for UK pharma investment, but delivery will decide whether they take root}, year = {2026}, howpublished = {StatOrigin, https://statorigin.org}, url = {https://statorigin.org/stat/stat_GMYPTHCR25PSS2A2G385G7T53M}, note = {Original source: https://www.abpi.org.uk/media/news/2026/august/green-shoots-for-uk-pharma-investment-but-delivery-will-decide-whether-they-take-root/. Accessed September 17, 2026.} }
Data published under CC BY 4.0. The citation credits the original publisher and links to this permanent record.
Provenance and verification
Everything needed to check this number yourself, without taking our word for it.
Primary source
- Publisher
- Association of the British Pharmaceutical Industry · homepage ↗
- Authority tier
- Tier 2 · National and industry official
- Report
- Green shoots for UK pharma investment, but delivery will decide whether they take root
- Type
- Press release
- Published
- —
- Locator
- UK competitive weaknesses
- Retrieved
- 17 September 2026
- Link status
- Reachable (HTTP 200)
- Report licence
- See source
Verification
- Status
- Verified
- Review protocol
- Editorial review
- Checked on
- 17 September 2026
- Last revision
- 17 September 2026
- Permanent URL
- /stat/stat_GMYPTHCR25PSS2A2G385G7T53M